aluates Reports

$ 0.0

Automative

Global Edoxaban Tosilate Tablets and Generic Drugs Market Research Report 2026

Published Date: 2026-01-23

Report Code: QYRE-Auto-32H18465

Global Edoxaban Tosilate Tablets and Generic Drugs Market Research Report 2024

BUY CHAPTERS

Global Edoxaban Tosilate Tablets and Generic Drugs Market Research Report 2026

Code: QYRE-Auto-32H18465

Report

2026-01-23

Pages:96

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Daiichi Sankyo

Menarini Group

Simcere Pharmaceutical

Lunan Pharmaceutical Group

Edoxaban Tosilate Tablets and Generic Drugs Market Size

The global Edoxaban Tosilate Tablets and Generic Drugs market was valued at US$ 1944 million in 2025 and is anticipated to reach US$ 2687 million by 2032, at a CAGR of 4.8% from 2026 to 2032.

Edoxaban Tosilate Tablets and Generic Drugs Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Edoxaban Tosilate Tablets and Generic Drugs competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Edoxaban is a member of the Novel Oral Anti-Coagulants (NOACs) class of drugs, and is a rapidly acting, oral, selective factor Xa inhibitor. By inhibiting factor Xa, a key protein in the coagulation cascade, edoxaban prevents the stepwise amplification of protein factors needed to form blood clots. It is indicated to reduce the risk of stroke and systemic embolism (SE) in patients with nonvalvular atrial fibrillation (NVAF) and for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) following 5-10 days of initial therapy with a parenteral anticoagulant. Traditionally, warfarin, a vitamin K antagonist, was used for stroke prevention in these individuals but effective use of this drug is limited by it's delayed onset, narrow therapeutic window, need for regular monitoring and INR testing, and numerous drug-drug and drug-food interactions. This has prompted enthusiasm for newer agents such as dabigatran, apixaban, and rivaroxaban for effective clot prevention. In addition to once daily dosing, the benefits over warfarin also include significant reductions in hemorrhagic stroke and GI bleeding, and improved compliance, which is beneficial as many patients will be on lifelong therapy.

The North American market for Edoxaban Tosilate Tablets and Generic Drugs is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Edoxaban Tosilate Tablets and Generic Drugs is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of Edoxaban Tosilate Tablets and Generic Drugs include Daiichi Sankyo, Menarini Group, Simcere Pharmaceutical, Lunan Pharmaceutical Group, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Edoxaban Tosilate Tablets and Generic Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Edoxaban Tosilate Tablets and Generic Drugs. The Edoxaban Tosilate Tablets and Generic Drugs market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Edoxaban Tosilate Tablets and Generic Drugs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Edoxaban Tosilate Tablets and Generic Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Edoxaban Tosilate Tablets and Generic Drugs Market Report

Report Metric	Details
Report Name	Edoxaban Tosilate Tablets and Generic Drugs Market
Accounted market size in 2025	US$ 1944 million
Forecasted market size in 2032	US$ 2687 million
CAGR	4.8%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	30 mg 60 mg Other
by Application	Hospital Clinic Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Daiichi Sankyo, Menarini Group, Simcere Pharmaceutical, Lunan Pharmaceutical Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Edoxaban Tosilate Tablets and Generic Drugs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Edoxaban Tosilate Tablets and Generic Drugs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Edoxaban Tosilate Tablets and Generic Drugs Market growing?

Ans: The Edoxaban Tosilate Tablets and Generic Drugs Market witnessing a CAGR of 4.8% during the forecast period 2026-2032.

What is the Edoxaban Tosilate Tablets and Generic Drugs Market size in 2032?

Ans: The Edoxaban Tosilate Tablets and Generic Drugs Market size in 2032 will be US$ 2687 million.

Who are the main players in the Edoxaban Tosilate Tablets and Generic Drugs Market report?

Ans: The main players in the Edoxaban Tosilate Tablets and Generic Drugs Market are Daiichi Sankyo, Menarini Group, Simcere Pharmaceutical, Lunan Pharmaceutical Group

What are the Application segmentation covered in the Edoxaban Tosilate Tablets and Generic Drugs Market report?

Ans: The Applications covered in the Edoxaban Tosilate Tablets and Generic Drugs Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Edoxaban Tosilate Tablets and Generic Drugs Market report?

Ans: The Types covered in the Edoxaban Tosilate Tablets and Generic Drugs Market report are 30 mg, 60 mg, Other

1 Edoxaban Tosilate Tablets and Generic Drugs Market Overview

1.1 Product Definition

1.2 Edoxaban Tosilate Tablets and Generic Drugs by Type

1.2.1 Global Edoxaban Tosilate Tablets and Generic Drugs Market Value by Type: 2025 vs 2032

1.2.2 30 mg

1.2.3 60 mg

1.2.4 Other

1.3 Edoxaban Tosilate Tablets and Generic Drugs by Application

1.3.1 Global Edoxaban Tosilate Tablets and Generic Drugs Market Value by Application: 2025 vs 2032

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Global Edoxaban Tosilate Tablets and Generic Drugs Market Size Estimates and Forecasts

1.4.1 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue 2021–2032

1.4.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales 2021–2032

1.4.3 Global Edoxaban Tosilate Tablets and Generic Drugs Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 Edoxaban Tosilate Tablets and Generic Drugs Market Competition by Manufacturers

2.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Manufacturers (2021–2026)

2.2 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Edoxaban Tosilate Tablets and Generic Drugs Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Edoxaban Tosilate Tablets and Generic Drugs, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Edoxaban Tosilate Tablets and Generic Drugs, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Edoxaban Tosilate Tablets and Generic Drugs, Product Types and Applications

2.7 Global Key Manufacturers of Edoxaban Tosilate Tablets and Generic Drugs, Date of Entry into the Industry

2.8 Global Edoxaban Tosilate Tablets and Generic Drugs Market Competitive Situation and Trends

2.8.1 Global Edoxaban Tosilate Tablets and Generic Drugs Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Edoxaban Tosilate Tablets and Generic Drugs Players Market Share by Revenue

2.8.3 Global Edoxaban Tosilate Tablets and Generic Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Edoxaban Tosilate Tablets and Generic Drugs Market Scenario by Region

3.1 Global Edoxaban Tosilate Tablets and Generic Drugs Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region: 2021–2032

3.2.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region: 2021–2026

3.2.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region: 2027–2032

3.3 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region: 2021–2032

3.3.1 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region: 2021–2026

3.3.2 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region: 2027–2032

3.4 North America Edoxaban Tosilate Tablets and Generic Drugs Market Facts & Figures by Country

3.4.1 North America Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021–2032)

3.4.3 North America Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Edoxaban Tosilate Tablets and Generic Drugs Market Facts & Figures by Country

3.5.1 Europe Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021–2032)

3.5.3 Europe Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Edoxaban Tosilate Tablets and Generic Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Edoxaban Tosilate Tablets and Generic Drugs Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales by Region (2021–2032)

3.6.3 Asia Pacific Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Edoxaban Tosilate Tablets and Generic Drugs Market Facts & Figures by Country

3.7.1 Latin America Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021–2032)

3.7.3 Latin America Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021–2032)

3.8.3 Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021–2032)

4.1.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021–2026)

4.1.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2027–2032)

4.1.3 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Type (2021–2032)

4.2 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type (2021–2032)

4.2.1 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type (2021–2026)

4.2.2 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type (2027–2032)

4.2.3 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Type (2021–2032)

4.3 Global Edoxaban Tosilate Tablets and Generic Drugs Price by Type (2021–2032)

5 Segment by Application

5.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021–2032)

5.1.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021–2026)

5.1.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2027–2032)

5.1.3 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Application (2021–2032)

5.2 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application (2021–2032)

5.2.1 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application (2021–2026)

5.2.2 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application (2027–2032)

5.2.3 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Application (2021–2032)

5.3 Global Edoxaban Tosilate Tablets and Generic Drugs Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Daiichi Sankyo

6.1.1 Daiichi Sankyo Company Information

6.1.2 Daiichi Sankyo Description and Business Overview

6.1.3 Daiichi Sankyo Edoxaban Tosilate Tablets and Generic Drugs Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Daiichi Sankyo Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio

6.1.5 Daiichi Sankyo Recent Developments/Updates

6.2 Menarini Group

6.2.1 Menarini Group Company Information

6.2.2 Menarini Group Description and Business Overview

6.2.3 Menarini Group Edoxaban Tosilate Tablets and Generic Drugs Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Menarini Group Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio

6.2.5 Menarini Group Recent Developments/Updates

6.3 Simcere Pharmaceutical

6.3.1 Simcere Pharmaceutical Company Information

6.3.2 Simcere Pharmaceutical Description and Business Overview

6.3.3 Simcere Pharmaceutical Edoxaban Tosilate Tablets and Generic Drugs Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Simcere Pharmaceutical Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio

6.3.5 Simcere Pharmaceutical Recent Developments/Updates

6.4 Lunan Pharmaceutical Group

6.4.1 Lunan Pharmaceutical Group Company Information

6.4.2 Lunan Pharmaceutical Group Description and Business Overview

6.4.3 Lunan Pharmaceutical Group Edoxaban Tosilate Tablets and Generic Drugs Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Lunan Pharmaceutical Group Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio

6.4.5 Lunan Pharmaceutical Group Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Edoxaban Tosilate Tablets and Generic Drugs Industry Chain Analysis

7.2 Edoxaban Tosilate Tablets and Generic Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Edoxaban Tosilate Tablets and Generic Drugs Production Mode & Process Analysis

7.4 Edoxaban Tosilate Tablets and Generic Drugs Sales and Marketing

7.4.1 Edoxaban Tosilate Tablets and Generic Drugs Sales Channels

7.4.2 Edoxaban Tosilate Tablets and Generic Drugs Distributors

7.5 Edoxaban Tosilate Tablets and Generic Drugs Customer Analysis

8 Edoxaban Tosilate Tablets and Generic Drugs Market Dynamics

8.1 Edoxaban Tosilate Tablets and Generic Drugs Industry Trends

8.2 Edoxaban Tosilate Tablets and Generic Drugs Market Drivers

8.3 Edoxaban Tosilate Tablets and Generic Drugs Market Challenges

8.4 Edoxaban Tosilate Tablets and Generic Drugs Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Daiichi Sankyo

Menarini Group

Simcere Pharmaceutical

Lunan Pharmaceutical Group

List of Tables

Table 1. Global Edoxaban Tosilate Tablets and Generic Drugs Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Edoxaban Tosilate Tablets and Generic Drugs Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Edoxaban Tosilate Tablets and Generic Drugs Market Competitive Situation by Manufacturers in 2025

Table 4. Global Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units) of Key Manufacturers (2021–2026)

Table 5. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Manufacturers (2021–2026)

Table 6. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market Edoxaban Tosilate Tablets and Generic Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of Edoxaban Tosilate Tablets and Generic Drugs, Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of Edoxaban Tosilate Tablets and Generic Drugs, Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of Edoxaban Tosilate Tablets and Generic Drugs, Product Types and Applications

Table 12. Global Key Manufacturers of Edoxaban Tosilate Tablets and Generic Drugs, Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Edoxaban Tosilate Tablets and Generic Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Edoxaban Tosilate Tablets and Generic Drugs Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Edoxaban Tosilate Tablets and Generic Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region (K Units), 2021–2026

Table 18. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Region (2021–2026)

Table 19. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region (K Units), 2027–2032

Table 20. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Region (2027–2032)

Table 21. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region (US$ Million), 2021–2026

Table 22. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Region (2021–2026)

Table 23. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region (US$ Million), 2027–2032

Table 24. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Region (2027–2032)

Table 25. North America Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (K Units), 2021–2026

Table 27. North America Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (K Units), 2027–2032

Table 28. North America Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country (US$ Million), 2021–2026

Table 29. North America Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country (US$ Million), 2027–2032

Table 30. Europe Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (K Units), 2021–2026

Table 32. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (K Units), 2027–2032

Table 33. Europe Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country (US$ Million), 2021–2026

Table 34. Europe Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales by Region (K Units), 2021–2026

Table 37. Asia Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales by Region (K Units), 2027–2032

Table 38. Asia Pacific Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (K Units), 2021–2026

Table 42. Latin America Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (K Units), 2027–2032

Table 43. Latin America Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (K Units), 2021–2026

Table 47. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (K Units), 2027–2032

Table 48. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country (US$ Million), 2027–2032

Table 50. Global Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units) by Type (2021–2026)

Table 51. Global Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units) by Type (2027–2032)

Table 52. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Type (2021–2026)

Table 53. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Type (2027–2032)

Table 54. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue (US$ Million) by Type (2021–2026)

Table 55. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue (US$ Million) by Type (2027–2032)

Table 56. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Type (2021–2026)

Table 57. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Type (2027–2032)

Table 58. Global Edoxaban Tosilate Tablets and Generic Drugs Price (US$/Unit) by Type (2021–2026)

Table 59. Global Edoxaban Tosilate Tablets and Generic Drugs Price (US$/Unit) by Type (2027–2032)

Table 60. Global Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units) by Application (2021–2026)

Table 61. Global Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units) by Application (2027–2032)

Table 62. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Application (2021–2026)

Table 63. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Application (2027–2032)

Table 64. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue (US$ Million) by Application (2021–2026)

Table 65. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue (US$ Million) by Application (2027–2032)

Table 66. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Application (2021–2026)

Table 67. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Application (2027–2032)

Table 68. Global Edoxaban Tosilate Tablets and Generic Drugs Price (US$/Unit) by Application (2021–2026)

Table 69. Global Edoxaban Tosilate Tablets and Generic Drugs Price (US$/Unit) by Application (2027–2032)

Table 70. Daiichi Sankyo Company Information

Table 71. Daiichi Sankyo Description and Business Overview

Table 72. Daiichi Sankyo Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 73. Daiichi Sankyo Edoxaban Tosilate Tablets and Generic Drugs Product

Table 74. Daiichi Sankyo Recent Developments/Updates

Table 75. Menarini Group Company Information

Table 76. Menarini Group Description and Business Overview

Table 77. Menarini Group Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 78. Menarini Group Edoxaban Tosilate Tablets and Generic Drugs Product

Table 79. Menarini Group Recent Developments/Updates

Table 80. Simcere Pharmaceutical Company Information

Table 81. Simcere Pharmaceutical Description and Business Overview

Table 82. Simcere Pharmaceutical Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 83. Simcere Pharmaceutical Edoxaban Tosilate Tablets and Generic Drugs Product

Table 84. Simcere Pharmaceutical Recent Developments/Updates

Table 85. Lunan Pharmaceutical Group Company Information

Table 86. Lunan Pharmaceutical Group Description and Business Overview

Table 87. Lunan Pharmaceutical Group Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 88. Lunan Pharmaceutical Group Edoxaban Tosilate Tablets and Generic Drugs Product

Table 89. Lunan Pharmaceutical Group Recent Developments/Updates

Table 90. Key Raw Materials Lists

Table 91. Raw Materials Key Suppliers Lists

Table 92. Edoxaban Tosilate Tablets and Generic Drugs Distributors List

Table 93. Edoxaban Tosilate Tablets and Generic Drugs Customers List

Table 94. Edoxaban Tosilate Tablets and Generic Drugs Market Trends

Table 95. Edoxaban Tosilate Tablets and Generic Drugs Market Drivers

Table 96. Edoxaban Tosilate Tablets and Generic Drugs Market Challenges

Table 97. Edoxaban Tosilate Tablets and Generic Drugs Market Restraints

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Product Picture of Edoxaban Tosilate Tablets and Generic Drugs

Figure 2. Global Edoxaban Tosilate Tablets and Generic Drugs Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Edoxaban Tosilate Tablets and Generic Drugs Market Share by Type: 2025 & 2032

Figure 4. 30 mg Product Picture

Figure 5. 60 mg Product Picture

Figure 6. Other Product Picture

Figure 7. Global Edoxaban Tosilate Tablets and Generic Drugs Market Value by Application (US$ Million), 2021–2032

Figure 8. Global Edoxaban Tosilate Tablets and Generic Drugs Market Share by Application: 2025 & 2032

Figure 9. Hospital

Figure 10. Clinic

Figure 11. Other

Figure 12. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 13. Global Edoxaban Tosilate Tablets and Generic Drugs Market Size (US$ Million), 2021–2032

Figure 14. Global Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units), 2021–2032

Figure 15. Global Edoxaban Tosilate Tablets and Generic Drugs Average Price (US$/Unit), 2021–2032

Figure 16. Edoxaban Tosilate Tablets and Generic Drugs Report Years Considered

Figure 17. Edoxaban Tosilate Tablets and Generic Drugs Sales Share by Manufacturers in 2025

Figure 18. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Share by Manufacturers in 2025

Figure 19. Top 5 and Top 10 Global Edoxaban Tosilate Tablets and Generic Drugs Players: Market Share by Revenue in Edoxaban Tosilate Tablets and Generic Drugs in 2025

Figure 20. Edoxaban Tosilate Tablets and Generic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 21. Global Edoxaban Tosilate Tablets and Generic Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 22. North America Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Country (2021–2032)

Figure 23. North America Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Country (2021–2032)

Figure 24. United States Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (US$ Million), 2021–2032

Figure 25. Canada Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (US$ Million), 2021–2032

Figure 26. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Country (2021–2032)

Figure 27. Europe Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Country (2021–2032)

Figure 28. Germany Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (US$ Million), 2021–2032

Figure 29. France Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. U.K. Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. Italy Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (US$ Million), 2021–2032

Figure 32. Russia Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (US$ Million), 2021–2032

Figure 33. Asia Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Region (2021–2032)

Figure 34. Asia Pacific Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Region (2021–2032)

Figure 35. China Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. Japan Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. South Korea Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. India Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. Australia Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. China Taiwan Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Southeast Asia Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Latin America Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Country (2021–2032)

Figure 43. Latin America Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Country (2021–2032)

Figure 44. Mexico Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Brazil Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Argentina Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Colombia Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Country (2021–2032)

Figure 49. Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Country (2021–2032)

Figure 50. Turkey Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Saudi Arabia Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. UAE Edoxaban Tosilate Tablets and Generic Drugs Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. Global Sales Market Share of Edoxaban Tosilate Tablets and Generic Drugs by Type (2021–2032)

Figure 54. Global Revenue Market Share of Edoxaban Tosilate Tablets and Generic Drugs by Type (2021–2032)

Figure 55. Global Edoxaban Tosilate Tablets and Generic Drugs Price (US$/Unit) by Type (2021–2032)

Figure 56. Global Sales Market Share of Edoxaban Tosilate Tablets and Generic Drugs by Application (2021–2032)

Figure 57. Global Revenue Market Share of Edoxaban Tosilate Tablets and Generic Drugs by Application (2021–2032)

Figure 58. Global Edoxaban Tosilate Tablets and Generic Drugs Price (US$/Unit) by Application (2021–2032)

Figure 59. Edoxaban Tosilate Tablets and Generic Drugs Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Oral Factor Xa Inhibitors Market Research Report 2024

Global Edoxaban API Market Research Report 2024

Global Direct Oral Anticoagulants DOACs Market Research Report 2024

Global Edoxaban Reagent Market Research Report 2024

Global Rivaroxaban Drugs Market Research Report 2024

Global Factor Xa Inhibitors Market Research Report 2024

Rivaroxaban API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global FXa Inhibitor Market Research Report 2025

Global Rivaroxaban Tablets Market Research Report 2024

Global Dabigatran Etexilate Drugs Market Research Report 2024

Global Rivaroxaban Market Insights Forecast to 2030

Global Dabigatran Etexilate Mesylate Market Research Report 2024

Global Dabigatran Etexilate Capsules Market Research Report 2024

Global Oral Anticoagulants Market Research Report 2024

Global Dabigatran Market Insights Forecast to 2030

Global Direct Oral Anticoagulant Market Insights Forecast to 2030

Global Enoxaparin Sodium Market Research Report 2024

Global Novel Oral Anticoagulants Drugs Market Insights Forecast to 2030

Global Warfarin Sodium Tablets Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions